Rexahn Site — Seattle, Washington

Rexahn Site is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Rexahn Site has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Cancer.

Sponsors: Rexahn Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Seattle

Browse all research sites in Washington · View every site in Seattle

• Cardiovascular Health Research Unit, University of Washington
• University of Washington Autism Center
• Dept. of Ophthalmology, University of Washington Medical Center
• VA Puget Sound Healthcare System, Seattle Division
• Seattle Cancer Care Alliance/University of Washington Medical Center
• Swedish Hospital Cherry Hill
• University of Washington School Medicine
• University of Washington Rhinology Clinic
• University of Washington Center for Pediatric Dentistry
• Seattle Children's Hospital - Infectious Diseases
• University of Washington Health Promotion Research Center
• University of Washington, Behavioral Research and Therapy Clinics

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rexahn Site?

Rexahn Site has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rexahn Site conducted?

Rexahn Site has 1 clinical trials on record. Their work covers Metastatic Renal Cell Cancer.

Is Rexahn Site accredited by Crixeo Clinical Trials?

Rexahn Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rexahn Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.